Merck’s Frazier Says He Won’t Follow Pfizer in Splitting Company

Merck & Co. Chief Executive Officer Ken Frazier said he doesn’t plan on breaking up the company by splitting off businesses the way Pfizer Inc. and Abbott Laboratories are doing.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.